ABCELLERA BIOLOGICS INC

AbCellera Biologics shares jump 4.53% in Friday trading, reaching $11.37 with a $4B market cap – see detailed market data and company insights.

Abcellera Biologics stocks climb 4.5% to $11.28, beating a 52‑week low, while Canadian peers hover near their own peaks and key corporate moves shape future growth.

Abcellera Biologics (ABCL) saw a modest 1.1% rise, trading at $11.71 amid a 5.8% monthly decline. Learn how its drug‑discovery tech keeps investors interested.

AbCellera Biologics faces volatility as biotech gains meet market skepticism—analyzing recent gains, liquidity, and strategic challenges in the high‑risk pharma sector.